WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Related articles:
Related suggestion:
UN chief to meet Ukrainian president in KyivWith secret contract, U.S. uses spyware to supervise world: NYTRescue underway after earthquake hits SyriaRetired general Pavel wins Czech presidential electionCPC Leadership Hears Work ReportsWorld Insights: WTO members confront U.S. abuse of security exception for protectionist purposeChina calls for intensified diplomatic efforts to end Ukraine crisisIAEA board to hold meeting over Zaporizhzhia attacksChina strong supporter of multilateral trading system, says WTO director(W.E. Talk) Tamara Prosic: How China and the World Benefit from Collectivism
3.0771s , 6499.1015625 kb
Copyright © 2024 Powered by New strategy to attack aggressive brain cancer shows promise ,Cosmic Chronicle news portal